The transient effect of dexamethasone on foetal cardiotocography in antenatal period
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20250852Keywords:
Antenatal corticosteroids, Dexamethasone, Preterm labour, Cardiotocography, Foetal heart rate variability, Foetal monitoringAbstract
Background: Preterm birth is a major contributor to neonatal morbidity and mortality worldwide. This study aimed to evaluate the impact of antenatal dexamethasone on CTG patterns, specifically FHR variability, accelerations, and foetal movements, in women at high risk of preterm labour.
Methods: A cross-sectional, comparative observational study was conducted in a Kamla Nehru hospital Shimla from June 23 to June 24. The study included 102 women aged 18-35 years, with a gestational age of 28-34 weeks, at risk for preterm delivery. Participants received a full course of dexamethasone (24 mg in divided doses 12 hours apart). CTG was recorded before administration and at 48- and 96-hours post-dexamethasone. Statistical analysis was performed using Chi-square tests with significance set at p<0.05.
Results: Before dexamethasone administration, all participants reported normal foetal movement, but 48 hours later, 53.9% reported decreased foetal movement (p<0.001). By 96 hours, the perception of foetal movement returned to normal in 98% of participants (p=0.498). FHR variability significantly decreased with moderate variability observed in 74.5% of cases at 48 hours (p<0.001). FHR accelerations decreased significantly from 94.1% before administration to 79.4% at 48 hours (p=0.002), but returned to baseline by 96 hours (p=0.774).
Conclusions: Dexamethasone administration resulted in transient changes in FHR patterns, including decreased accelerations, decreased moderate variability, and reduced foetal movement within the first 48 hours. However, these effects were short-lived, with normalization occurring by 96 hours.
Metrics
References
Ananya A, Pal M, Bhadra B, Sarkar S. Effect of dexamethasone on fetal heart rate variability, by non-invasive non-stress test tracing in preterm labour. Int J Reprod Contracept Obstet Gynecol. 2023;12(3):584-90. DOI: https://doi.org/10.18203/2320-1770.ijrcog20230353
Ali MA, Bayoumy HA, Elshabrawy AS. Effect of maternal dexamethasone administration on daily fetal movement count and its correlation with Doppler studies and cardiotocography. Int J Reprod Contracept Obstet Gynecol. 2021;10:2565-70. DOI: https://doi.org/10.18203/2320-1770.ijrcog20212352
Durrani H, Malik SI, Saif A, Rizwan W, Khokhar S, Nasir A, Kouser S. Dexamethasone and fetal behaviour: A cohort study of the effects of maternal dexamethasone administration on fetal heart rate and movement. P J M H S. 2020;14(4):861-63.
Popoola MA, Ohaeri B, Ojo IO, Babarimisa O. Preterm Birth, Prevention, Prediction, Care. Eur J Med Heal Sci. 2023;5(1):6-10. DOI: https://doi.org/10.24018/ejmed.2023.5.1.1441
Griggs KM, Hrelic DA, Williams N, McEwen-Campbell M, Cypher R. Preterm labor and birth: a clinical review. Am J Maternal Child Nursing. 2020;45(6):328-37. DOI: https://doi.org/10.1097/NMC.0000000000000656
da Fonseca EB, Damião R, Moreira DA. Preterm birth prevention. Best Practi Res Clin Obstetr Gynaecol. 2020;69:40-9. DOI: https://doi.org/10.1016/j.bpobgyn.2020.09.003
Mwita S, Jande M, Katabalo D, Kamala B, Dewey D. Reducing neonatal mortality and respiratory distress syndrome associated with preterm birth: a scoping review on the impact of antenatal corticosteroids in low-and middle-income countries. World J Pediatr. 2021;17:131-40. DOI: https://doi.org/10.1007/s12519-020-00398-6
Uggioni ML, Colonetti T, Grande AJ, Cruz MV, da Rosa MI. Corticosteroids in pregnancy for preventing RDS: overview of systematic reviews. Reproduct Sci. 2022;29(1):54-68. DOI: https://doi.org/10.1007/s43032-020-00425-x
Daskalakis G, Pergialiotis V, Domellöf M, Ehrhardt H, Di Renzo GC, Koç E, et al. European guidelines on perinatal care: corticosteroids for women at risk of preterm birth. J Maternal Fetal Neonatal Med. 2023;36(1):2160628. DOI: https://doi.org/10.1080/14767058.2022.2160628
Alanwar A, Akl S, Hanafi S, Mohamed N. Effect of dexamethasone on daily fetal movement, umbilical and middle cerebral arteries Doppler and cardiotocogram. Int J Reprod Contracept Obstet Gynecol. 2021;10(11):4041-8. DOI: https://doi.org/10.18203/2320-1770.ijrcog20214308
Ciapponi A, Klein K, Colaci D, Althabe F, Belizán JM, Deegan A, et al. Dexamethasone versus betamethasone for preterm birth: a systematic review and network meta-analysis. Am J Obstetr Gynecol. 2021;3(3):100312. DOI: https://doi.org/10.1016/j.ajogmf.2021.100312
Dagklis T, Tsakiridis I, Papazisis G, Athanasiadis A. Efficacy and safety of corticosteroids’ administration for pulmonary immaturity in anticipated preterm delivery. Curr Pharmaceut Design. 2021;27(36):3754-61. DOI: https://doi.org/10.2174/1381612826666201207102910
Walters AG, Lin L, Crowther CA, Gamble GD, Dalziel SR, Harding JE. Betamethasone for preterm birth: Auckland Steroid Trial full results and new insights 50 years on. J Pediatr. 2023;255:80-8. DOI: https://doi.org/10.1016/j.jpeds.2022.10.028
Eddy KE, Vogel JP, Scott N, Fetene D, Tidhar T, Oladapo OT, et al. Antenatal dexamethasone for improving preterm newborn outcomes in low-resource countries: a cost-effectiveness analysis of the WHO ACTION-I trial. Lancet Global Health. 2022;10(10):e1523-33. DOI: https://doi.org/10.1016/S2214-109X(22)00340-0
Fee EL, Stock SJ, Kemp MW. Antenatal steroids: benefits, risks, and new insights. J Endocrinol. 2023;258(2):e220306. DOI: https://doi.org/10.1530/JOE-22-0306
Henry A, Mahajan A, Crowther CA, Lainchbury A, Roberts L, Shand AW, Welsh AW. Short-term effects of dexamethasone versus betamethasone on ultrasonic measures of fetal well-being: cohort from a blinded, randomized trial. Fetal Diagn Ther. 2021;48(7):526-40. DOI: https://doi.org/10.1159/000517623
Ahmed AA, Sayed Ahmed WA, Taha OT. Effect of dexamethasone on antepartum cardiotocography. Austin J Obstet Gynecol. 2021;8(1):1160. DOI: https://doi.org/10.26420/austiniobstetgynecol.2021.1160
Cao G, Liu J, Liu M. Global, regional, and national incidence and mortality of neonatal preterm birth, 1990-2019. JAMA pediatrics. 2022;176(8):787-96. DOI: https://doi.org/10.1001/jamapediatrics.2022.1622
Ishrat N, Perween S, Navi Khan GA. Effect of Antenatal Corticosteroid on Cardiotocographic Parameters in Pregnant Women. Indian J Publ Heal Res Develop. 2024;15(3):313-7. DOI: https://doi.org/10.37506/4zyt3y86
Rotmensch S, Liberati M, Vishne T, Celentano C, Ben-Rafael Z, Bellati U. The effect of betamethasone and dexamethasone on fetal heart rate patterns and biophysical activities, A prospective randomized trial. Acta Obstet Gynecol Scand. 1999;78(6):493-500. DOI: https://doi.org/10.1080/j.1600-0412.1999.780604.x
Chaurasia A, Singh V. Effect of antenatal betamethasone and dexamethasone on maternal blood glucose levels, fetal movement, NST parameters, and umbilical artery Doppler. J Matern Child Health. 2022;07(03):316-25. DOI: https://doi.org/10.26911/thejmch.2022.07.03.08
Downloads
Published
How to Cite
Issue
Section
